Combination of the PI3K Inhibitor ZSTK474 with a PSMA-Targeted Immunotoxin Accelerates Apoptosis and Regression of Prostate Cancer

The phosphoinositide 3-kinase (PI3K) pathway is activated in most advanced prostate cancers, yet so far treatments with PI3K inhibitors have been at best tumorostatic in preclinical cancer models and do not show significant antitumor efficacy in clinical trials. Results from tissue culture experimen...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Baiz, Daniele, Hassan, Sazzad, Choi, Young A, Flores, Anabel, Karpova, Yelena, Yancey, Dana, Pullikuth, Ashok, Sui, Guangchao, Sadelain, Michel, Debinski, Waldemar, Kulik, George
Format: Artigo
Jezik:Inglês
Izdano: Neoplasia Press Inc. 2013
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3819633/
https://ncbi.nlm.nih.gov/pubmed/24204196
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki